vs

Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and TRUSTCO BANK CORP N Y (TRST). Click either name above to swap in a different company.

TRUSTCO BANK CORP N Y is the larger business by last-quarter revenue ($49.5M vs $35.2M, roughly 1.4× NATIONAL RESEARCH CORP). TRUSTCO BANK CORP N Y runs the higher net margin — 32.9% vs 5.1%, a 27.8% gap on every dollar of revenue. Over the past eight quarters, TRUSTCO BANK CORP N Y's revenue compounded faster (6.8% CAGR vs -0.2%).

National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.

TRUSTCO BANK CORP N Y is a regional U.S. financial holding company that provides a full suite of retail and commercial banking products and services, including personal deposit accounts, mortgage loans, small business financing, and wealth management solutions. It primarily operates across New York, Florida, and several other U.S. states, serving individual consumers and small business client segments.

NRC vs TRST — Head-to-Head

Bigger by revenue
TRST
TRST
1.4× larger
TRST
$49.5M
$35.2M
NRC
Higher net margin
TRST
TRST
27.8% more per $
TRST
32.9%
5.1%
NRC
Faster 2-yr revenue CAGR
TRST
TRST
Annualised
TRST
6.8%
-0.2%
NRC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NRC
NRC
TRST
TRST
Revenue
$35.2M
$49.5M
Net Profit
$1.8M
$16.3M
Gross Margin
Operating Margin
13.3%
Net Margin
5.1%
32.9%
Revenue YoY
-4.6%
Net Profit YoY
-72.6%
14.1%
EPS (diluted)
$49.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRC
NRC
TRST
TRST
Q1 26
$49.5M
Q4 25
$35.2M
$48.2M
Q3 25
$34.6M
$47.8M
Q2 25
$34.0M
$46.6M
Q1 25
$33.6M
$45.3M
Q4 24
$36.9M
$43.3M
Q3 24
$35.8M
$43.6M
Q2 24
$35.0M
$43.4M
Net Profit
NRC
NRC
TRST
TRST
Q1 26
$16.3M
Q4 25
$1.8M
$15.6M
Q3 25
$4.1M
$16.3M
Q2 25
$-106.0K
$15.0M
Q1 25
$5.8M
$14.3M
Q4 24
$6.6M
$11.3M
Q3 24
$5.7M
$12.9M
Q2 24
$6.2M
$12.6M
Operating Margin
NRC
NRC
TRST
TRST
Q1 26
Q4 25
13.3%
43.7%
Q3 25
22.4%
44.6%
Q2 25
4.7%
42.3%
Q1 25
25.6%
41.3%
Q4 24
26.0%
34.0%
Q3 24
22.3%
38.8%
Q2 24
25.3%
37.9%
Net Margin
NRC
NRC
TRST
TRST
Q1 26
32.9%
Q4 25
5.1%
32.3%
Q3 25
11.9%
34.0%
Q2 25
-0.3%
32.3%
Q1 25
17.2%
31.5%
Q4 24
17.8%
26.0%
Q3 24
15.9%
29.5%
Q2 24
17.6%
28.9%
EPS (diluted)
NRC
NRC
TRST
TRST
Q1 26
Q4 25
$49.58
$0.85
Q3 25
$0.18
$0.86
Q2 25
$-0.01
$0.79
Q1 25
$0.25
$0.75
Q4 24
$0.27
$0.59
Q3 24
$0.24
$0.68
Q2 24
$0.26
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRC
NRC
TRST
TRST
Cash + ST InvestmentsLiquidity on hand
$4.1M
Total DebtLower is stronger
$112.9M
Stockholders' EquityBook value
$14.0M
$670.9M
Total Assets
$134.9M
$6.5B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRC
NRC
TRST
TRST
Q1 26
Q4 25
$4.1M
$730.4M
Q3 25
$2.2M
$695.6M
Q2 25
$5.3M
$713.6M
Q1 25
$2.5M
$756.1M
Q4 24
$4.2M
$641.8M
Q3 24
$3.5M
$523.0M
Q2 24
$485.0K
$536.1M
Total Debt
NRC
NRC
TRST
TRST
Q1 26
$112.9M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$48.7M
Q2 24
$33.3M
Stockholders' Equity
NRC
NRC
TRST
TRST
Q1 26
$670.9M
Q4 25
$14.0M
$686.6M
Q3 25
$14.3M
$692.0M
Q2 25
$21.3M
$692.8M
Q1 25
$29.7M
$687.8M
Q4 24
$31.3M
$676.3M
Q3 24
$34.6M
$669.0M
Q2 24
$40.2M
$655.2M
Total Assets
NRC
NRC
TRST
TRST
Q1 26
$6.5B
Q4 25
$134.9M
$6.4B
Q3 25
$135.7M
$6.3B
Q2 25
$141.4M
$6.3B
Q1 25
$135.2M
$6.3B
Q4 24
$132.5M
$6.2B
Q3 24
$131.8M
$6.1B
Q2 24
$119.1M
$6.1B
Debt / Equity
NRC
NRC
TRST
TRST
Q1 26
0.17×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.41×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRC
NRC
TRST
TRST
Operating Cash FlowLast quarter
$7.2M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
17.2%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
3.99×
TTM Free Cash FlowTrailing 4 quarters
$15.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRC
NRC
TRST
TRST
Q1 26
Q4 25
$7.2M
$57.6M
Q3 25
$13.8M
$12.8M
Q2 25
$-1.1M
$27.1M
Q1 25
$6.6M
$1.3M
Q4 24
$6.4M
$59.4M
Q3 24
$9.4M
$16.5M
Q2 24
$6.8M
$18.7M
Free Cash Flow
NRC
NRC
TRST
TRST
Q1 26
Q4 25
$6.1M
$45.7M
Q3 25
$10.2M
$10.0M
Q2 25
$-4.1M
$24.9M
Q1 25
$3.7M
$-3.3M
Q4 24
$1.9M
$54.6M
Q3 24
$7.8M
$15.6M
Q2 24
$1.5M
$17.6M
FCF Margin
NRC
NRC
TRST
TRST
Q1 26
Q4 25
17.2%
95.0%
Q3 25
29.4%
20.9%
Q2 25
-12.2%
53.5%
Q1 25
10.9%
-7.2%
Q4 24
5.2%
126.0%
Q3 24
21.8%
35.7%
Q2 24
4.3%
40.5%
Capex Intensity
NRC
NRC
TRST
TRST
Q1 26
Q4 25
3.2%
24.6%
Q3 25
10.4%
5.9%
Q2 25
8.8%
4.5%
Q1 25
8.9%
10.0%
Q4 24
12.0%
11.3%
Q3 24
4.5%
2.1%
Q2 24
15.0%
2.6%
Cash Conversion
NRC
NRC
TRST
TRST
Q1 26
Q4 25
3.99×
3.70×
Q3 25
3.34×
0.79×
Q2 25
1.80×
Q1 25
1.15×
0.09×
Q4 24
0.97×
5.27×
Q3 24
1.66×
1.28×
Q2 24
1.10×
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NRC
NRC

Segment breakdown not available.

TRST
TRST

Net Interest Income$44.7M90%
Noninterest Income$4.8M10%

Related Comparisons